Diplomat Enhances Corporate Governance With Appointment of Ben Wolin to Newly-Created Role of Lead Director

02/14/2017

FLINT, Mich., Feb. 14, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, today announced the appointment of Ben Wolin as independent Lead Director, effective immediately. Mr. Wolin, a member of the Company's Nominating and Corporate Governance Committee and its Audit Committee, was appointed to the newly created position by the Company's independent directors.

Phil Hagerman, chairman and CEO of Diplomat, commented, "The appointment of a lead director is a continuation of Diplomat's growing corporate governance practices. Ben possesses the extensive healthcare experience and broad perspective critical to oversee the efficient running of Diplomat's governance structure while upholding the interests of our shareholders." "I am honored to be appointed by the Company's independent directors to this new position," said Mr. Wolin. "I understand the important role that a lead director can play in ensuring that a board appropriately monitors the management team while providing strong independent leadership and strategic guidance. I look forward to continuing to work with the Board to further enhance value for all Diplomat shareholders."

About Ben Wolin

Ben Wolin has been a member of Diplomat's Board since October 2015. Mr. Wolin served as the co-founder, Chief Executive Officer and a member of the board of directors of Everyday Health, Inc. (NYSE: EVDY), a leading provider of digital health and wellness solutions, from January 2002 until its sale in December 2016. From September 1999 until December 2001, Mr. Wolin served as Vice President of Production and Technology for Beliefnet, Inc., an online provider of religious and spiritual information. Previously, Mr. Wolin served as Web Producer for Tribune Interactive, Inc., a multimedia corporation, and held several consulting positions with interactive companies.

About Diplomat

Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.

Investor Contact:
Bob East, Westwicke Partners 
443-213-0500 | diplomat@westwicke.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diplomat-enhances-corporate-governance-with-appointment-of-ben-wolin-to-newly-created-role-of-lead-director-300407223.html

SOURCE Diplomat Pharmacy, Inc.

NYSE: DPLO

+0.28 +1.33% $ 21.39 Volume: 266,668 Common Stock | 20 minute delay September 26, 2017

Investor Contact

Asher S. Dewhurst

Investor Relations,
Westwicke Partners, LLC.
diplomat@westwicke.com

Phone: 443.213.0500

Email Now